Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Lawrence Banks

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequence

Phenomena

Protein Binding

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
34
Massimi, Paola
30
Pim, David
22
Thomas, Miranda
15
Matlashewski, Greg
14
Storey, Alan
12
Gardiol, Daniela
8
Kühne, Christian
7
Mantovani, Fiamma
6
Javier, Ronald
6
Gammoh, Noor
5
Glaunsinger, Britt
5
Guccione, Ernesto
5
Bouvard, Veronique
4
Grm, Helena Sterlinko
3
Ivanova, Saska

Sign-in to see all Coauthors

Publications

TOP 3
Tomaic Vjekoslav; Pim David; Banks Lawrence
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
Pim David; Tomaic Vjekoslav; Banks Lawrence
The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.
Grm Helena Sterlinko; Bergant Martina; Banks Lawrence
Human papillomavirus infection, cancer & therapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Lawrence Banks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tomaic Vjekoslav; Pim David; Banks Lawrence
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
Virology 2009;393(1):7-10.
2009: Pim David; Tomaic Vjekoslav; Banks Lawrence
The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.
Journal of virology 2009;83(19):9863-74.
2009: Grm Helena Sterlinko; Bergant Martina; Banks Lawrence
Human papillomavirus infection, cancer & therapy.
The Indian journal of medical research 2009;130(3):277-85.
2009: Gammoh N; Isaacson E; Tomaic V; Jackson D J; Doorbar J; Banks L
Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2.
Oncogene 2009;28(23):2299-304.
2009: Gammoh Noor; Gardiol Daniela; Massimi Paola; Banks Lawrence
The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2.
Journal of virology 2009;83(3):1538-43.
2009: Tomaic V; Gardiol D; Massimi P; Ozbun M; Myers M; Banks L
Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.
Oncogene 2009;28(1):1-8.
2008: Massimi Paola; Narayan Nisha; Thomas Miranda; Gammoh Noor; Strand Susanne; Strand Dennis; Banks Lawrence
Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complex.
Experimental cell research 2008;314(18):3306-17.
2008: Cavatorta Ana Laura; Giri Adriana A; Banks Lawrence; Gardiol Daniela
Cloning and functional analysis of the promoter region of the human Disc large gene.
Gene 2008;424(1-2):87-95.
2008: Massimi P; Shai A; Lambert P; Banks L
HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
Oncogene 2008;27(12):1800-4.
2008: Massimi Paola; Thomas Miranda; Bouvard Veronique; Ruberto Irene; Campo M Saveria; Tommasino Massimo; Banks Lawrence
Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer.
Virology 2008;371(2):374-9.
2008: Ainsworth Julia; Thomas Miranda; Banks Lawrence; Coutlee Francois; Matlashewski Greg
Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses.
Virology journal 2008;5():67.
2007: Ivanova Saska; Repnik Urska; Banks Lawrence; Turk Vito; Turk Boris
Cellular localization of MAGI-1 caspase cleavage products and their role in apoptosis.
Biological chemistry 2007;388(11):1195-8.
2007: Gregorc Uros; Ivanova Saska; Thomas Miranda; Guccione Ernesto; Glaunsinger Britt; Javier Ron; Turk Vito; Banks Lawrence; Turk Boris
Cleavage of MAGI-1, a tight junction PDZ protein, by caspases is an important step for cell-cell detachment in apoptosis.
Apoptosis : an international journal on programmed cell death 2007;12(2):343-54.
2006: Gardiol Daniela; Zacchi Alberto; Petrera Francesca; Stanta Giorgio; Banks Lawrence
Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression.
International journal of cancer. Journal international du cancer 2006;119(6):1285-90.
2006: Massimi P; Narayan N; Cuenda A; Banks L
Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation.
Oncogene 2006;25(31):4276-85.
2006: Gammoh Noor; Grm Helena Sterlinko; Massimi Paola; Banks Lawrence
Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
Journal of virology 2006;80(4):1787-97.
2005: Pim David; Massimi Paola; Dilworth Stephen M; Banks Lawrence
Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A.
Oncogene 2005;24(53):7830-8.
2005: Thomas Miranda; Massimi Paola; Navarro Christel; Borg Jean-Paul; Banks Lawrence
The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.
Oncogene 2005;24(41):6222-30.
2005: Grm Helena Sterlinko; Massimi Paola; Gammoh Noor; Banks Lawrence
Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.
Oncogene 2005;24(33):5149-64.
2005: Gregorc Uros; Ivanova Saska; Thomas Miranda; Turk Vito; Banks Lawrence; Turk Boris
hDLG/SAP97, a member of the MAGUK protein family, is a novel caspase target during cell-cell detachment in apoptosis.
Biological chemistry 2005;386(7):705-10.
2005: Massimi Paola; Banks Lawrence
Transformation assays for HPV oncoproteins.
Methods in molecular medicine 2005;119():381-95.
2004: Sterlinko Grm Helena; Banks Lawrence
HPV proteins as targets for therapeutic intervention.
Antiviral therapy 2004;9(5):665-78.
2004: Grm Helena Sterlinko; Banks Lawrence
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent.
The Journal of general virology 2004;85(Pt 10):2815-9.
2004: Massimi Paola; Gammoh Noor; Thomas Miranda; Banks Lawrence
HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.
Oncogene 2004;23(49):8033-9.
2004: Cavatorta Ana Laura; Fumero Gastón; Chouhy Diego; Aguirre Roxana; Nocito Ana Lía; Giri Adriana A; Banks Lawrence; Gardiol Daniela
Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy.
International journal of cancer. Journal international du cancer 2004;111(3):373-80.
2004: Guccione Ernesto; Pim David; Banks Lawrence
HPV-18 E6*I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner.
International journal of cancer. Journal international du cancer 2004;110(6):928-33.
2004: Stewart Deborah; Kazemi Shirin; Li Suiyang; Massimi Paola; Banks Lawrence; Koromilas Antonis E; Matlashewski Greg
Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.
The Journal of general virology 2004;85(Pt 6):1419-26.
2004: Guccione Ernesto; Lethbridge Katherine J; Killick Neil; Leppard Keith N; Banks Lawrence
HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures.
Oncogene 2004;23(27):4662-72.
2004: Sterlinko Grm Helena; Weber Malte; Elston Rob; McIntosh Pauline; Griffin Heather; Banks Lawrence; Doorbar John
Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.
Journal of molecular biology 2004;335(4):971-85.
2004: Pim David; Banks Lawrence
p53 polymorphic variants at codon 72 exert different effects on cell cycle progression.
International journal of cancer. Journal international du cancer 2004;108(2):196-9.
2003: Kühne Christian; Tjörnhammar Marie-Louise; Pongor Sándor; Banks Lawrence; Simoncsits András
Repair of a minimal DNA double-strand break by NHEJ requires DNA-PKcs and is controlled by the ATM/ATR checkpoint.
Nucleic acids research 2003;31(24):7227-37.
2003: Massimi Paola; Gardiol Daniela; Roberts Sally; Banks Lawrence
Redistribution of the discs large tumor suppressor protein during mitosis.
Experimental cell research 2003;290(2):265-74.
2003: Mantovani Fiamma; Banks Lawrence
Regulation of the discs large tumor suppressor by a phosphorylation-dependent interaction with the beta-TrCP ubiquitin ligase receptor.
The Journal of biological chemistry 2003;278(43):42477-86.
2003: Bernat Agnieszka; Avvakumov Nikita; Mymryk Joe S; Banks Lawrence
Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.
Oncogene 2003;22(39):7871-81.
2003: Banks Lawrence; Pim David; Thomas Miranda
Viruses and the 26S proteasome: hacking into destruction.
Trends in biochemical sciences 2003;28(8):452-9.
2002: Prathapam Tulasiram; Kühne Christian; Banks Lawrence
Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity.
Nucleic acids research 2002;30(23):5261-8.
2002: Pim David; Thomas Miranda; Banks Lawrence
Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Oncogene 2002;21(53):8140-8.
2002: Thomas Miranda; Laura Richard; Hepner Karin; Guccione Ernesto; Sawyers Charles; Lasky Laurence; Banks Lawrence
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.
Oncogene 2002;21(33):5088-96.
2002: Bernat Agnieszka; Massimi Paola; Banks Lawrence
Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins.
The Journal of general virology 2002;83(Pt 4):829-33.
2002: Guccione Ernesto; Massimi Paola; Bernat Agnieszka; Banks Lawrence
Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins.
Virology 2002;293(1):20-5.
2002: Gardiol Daniela; Galizzi Silvina; Banks Lawrence
Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation.
The Journal of general virology 2002;83(Pt 2):283-9.
2001: Mantovani F; Massimi P; Banks L
Proteasome-mediated regulation of the hDlg tumour suppressor protein.
Journal of cell science 2001;114(Pt 23):4285-92.
2001: Massimi P; Pim D; Kühne C; Banks L
Regulation of the human papillomavirus oncoproteins by differential phosphorylation.
Molecular and cellular biochemistry 2001;227(1-2):137-44.
2001: Mantovani F; Banks L
The human papillomavirus E6 protein and its contribution to malignant progression.
Oncogene 2001;20(54):7874-87.
2001: Prathapam T; Kühne C; Banks L
The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
Oncogene 2001;20(52):7677-85.
2001: Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
Oncogene 2001;20(39):5431-9.
2001: Prathapam T; Kühne C; Hayman M; Banks L
Ski interacts with the evolutionarily conserved SNW domain of Skip.
Nucleic acids research 2001;29(17):3469-76.
2000: Jackson S; Harwood C; Thomas M; Banks L; Storey A
Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins.
Genes & development 2000;14(23):3065-73.
2000: Kühne C; Gardiol D; Guarnaccia C; Amenitsch H; Banks L
Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6.
Oncogene 2000;19(51):5884-91.
2000: Glaunsinger B A; Lee S S; Thomas M; Banks L; Javier R
Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.
Oncogene 2000;19(46):5270-80.
2000: Massimi P; Banks L
Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle.
Virology 2000;276(2):388-94.
2000: Lee S S; Glaunsinger B; Mantovani F; Banks L; Javier R T
Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.
Journal of virology 2000;74(20):9680-93.
2000: Marcello A; Massimi P; Banks L; Giacca M
Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300.
Journal of virology 2000;74(19):9090-8.
2000: Perea S E; Massimi P; Banks L
Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1.
International journal of molecular medicine 2000;5(6):661-6.
2000: Zwerschke W; Mannhardt B; Massimi P; Nauenburg S; Pim D; Nickel W; Banks L; Reuser A J; Jansen-Dürr P
Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein.
The Journal of biological chemistry 2000;275(13):9534-41.
2000: Pim D; Thomas M; Javier R; Gardiol D; Banks L
HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
Oncogene 2000;19(6):719-25.
1999: Mantovani F; Banks L
The interaction between p53 and papillomaviruses.
Seminars in cancer biology 1999;9(6):387-95.
1999: Massimi P; Pim D; Bertoli C; Bouvard V; Banks L
Interaction between the HPV-16 E2 transcriptional activator and p53.
Oncogene 1999;18(54):7748-54.
1999: Thomas M; Pim D; Banks L
The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
Oncogene 1999;18(53):7690-700.
1999: Pim D; Banks L
HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.
Oncogene 1999;18(52):7403-8.
1999: Gardiol D; Kühne C; Glaunsinger B; Lee S S; Javier R; Banks L
Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.
Oncogene 1999;18(40):5487-96.
1999: Thomas M; Banks L
Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.
The Journal of general virology 1999;80 ( Pt 6)():1513-7.
1999: Mantovani F; Banks L
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
Oncogene 1999;18(22):3309-15.
1999: Zwerschke W; Mazurek S; Massimi P; Banks L; Eigenbrodt E; Jansen-Dürr P
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(4):1291-6.
1999: Thomas M; Kalita A; Labrecque S; Pim D; Banks L; Matlashewski G
Two polymorphic variants of wild-type p53 differ biochemically and biologically.
Molecular and cellular biology 1999;19(2):1092-100.
1998: Thomas M; Banks L
Inhibition of Bak-induced apoptosis by HPV-18 E6.
Oncogene 1998;17(23):2943-54.
1998: Kühne C; Banks L
E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box.
The Journal of biological chemistry 1998;273(51):34302-9.
1998: Gardiol D; Banks L
Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
The Journal of general virology 1998;79 ( Pt 8)():1963-70.
1998: Storey A; Thomas M; Kalita A; Harwood C; Gardiol D; Mantovani F; Breuer J; Leigh I M; Matlashewski G; Banks L
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.
Nature 1998;393(6682):229-34.
1997: Massimi P; Pim D; Banks L
Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
The Journal of general virology 1997;78 ( Pt 10)():2607-13.
1997: Piccini A; Storey A; Romanos M; Banks L
Regulation of human papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and epidermal growth factor.
The Journal of general virology 1997;78 ( Pt 8)():1963-70.
1997: Pim D; Massimi P; Banks L
Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.
Oncogene 1997;15(3):257-64.
1997: Massimi P; Banks L
Repression of p53 transcriptional activity by the HPV E7 proteins.
Virology 1997;227(1):255-9.
1996: Thomas M; Massimi P; Banks L
HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.
Oncogene 1996;13(3):471-80.
1996: Thomas M; Matlashewski G; Pim D; Banks L
Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Oncogene 1996;13(2):265-73.
1996: Massimi P; Pim D; Storey A; Banks L
HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Oncogene 1996;12(11):2325-30.
1995: Piccini A; Storey A; Massimi P; Banks L
Mutations in the human papillomavirus type 16 E2 protein identify multiple regions of the protein involved in binding to E1.
The Journal of general virology 1995;76 ( Pt 11)():2909-13.
1995: Storey A; Massimi P; Dawson K; Banks L
Conditional immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53.
Oncogene 1995;11(4):653-61.
1995: Valle G F; Banks L
The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells.
The Journal of general virology 1995;76 ( Pt 5)():1239-45.
1995: Storey A; Piccini A; Massimi P; Bouvard V; Banks L
Mutations in the human papillomavirus type 16 E2 protein identify a region of the protein involved in binding to E1 protein.
The Journal of general virology 1995;76 ( Pt 4)():819-26.
1995: Thomas M; Massimi P; Jenkins J; Banks L
HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation.
Oncogene 1995;10(2):261-8.
1994: Bouvard V; Storey A; Pim D; Banks L
Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
The EMBO journal 1994;13(22):5451-9.
1994: Bouvard V; Matlashewski G; Gu Z M; Storey A; Banks L
The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.
Virology 1994;203(1):73-80.
1994: Pim D; Storey A; Thomas M; Massimi P; Banks L
Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
Oncogene 1994;9(7):1869-76.
1994: Gu Z; Pim D; Labrecque S; Banks L; Matlashewski G
DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6.
Oncogene 1994;9(2):629-33.
1993: Storey A; Banks L
Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells.
Oncogene 1993;8(4):919-24.
1992: Storey A; Greenfield I; Banks L; Pim D; Crook T; Crawford L; Stanley M
Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes.
Oncogene 1992;7(3):459-65.
1992: Pim D; Collins M; Banks L
Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.
Oncogene 1992;7(1):27-32.
1992: Leechanachai P; Banks L; Moreau F; Matlashewski G
The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus.
Oncogene 1992;7(1):19-25.
1991: Storey A; Oates D; Banks L; Crawford L; Crook T
Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.
Nucleic acids research 1991;19(15):4109-14.
1991: Pim D; Banks L
Loss of HPV-16 E7 dependence in cells transformed by HPV-16 E7 plus EJ-ras correlates with increased c-myc expression.
Oncogene 1991;6(4):589-94.
1991: Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(6):2037-42.
1990: Banks L; Edmonds C; Vousden K H
Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
Oncogene 1990;5(9):1383-9.
1990: Lees E; Osborn K; Banks L; Crawford L
Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.
The Journal of general virology 1990;71 ( Pt 1)():183-93.
1989: Crook T; Morgenstern J P; Crawford L; Banks L
Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.
The EMBO journal 1989;8(2):513-9.
1988: Matlashewski G; Osborn K; Banks L; Stanley M; Crawford L
Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras.
International journal of cancer. Journal international du cancer 1988;42(2):232-8.
1988: Banks L; Crawford L
Analysis of human papillomavirus type 16 polypeptides in transformed primary cells.
Virology 1988;165(1):326-8.
1988: Storey A; Pim D; Murray A; Osborn K; Banks L; Crawford L
Comparison of the in vitro transforming activities of human papillomavirus types.
The EMBO journal 1988;7(6):1815-20.
1987: Banks L; Matlashewski G; Pim D; Churcher M; Roberts C; Crawford L
Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
The Journal of general virology 1987;68 ( Pt 12)():3081-9.
1987: Matlashewski G; Schneider J; Banks L; Jones N; Murray A; Crawford L
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.
The EMBO journal 1987;6(6):1741-6.
1987: Matlashewski G; Pim D; Banks L; Crawford L
Alternative splicing of human p53 transcripts.
Oncogene research 1987;1(1):77-85.
1987: Banks L; Spence P; Androphy E; Hubbert N; Matlashewski G; Murray A; Crawford L
Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas.
The Journal of general virology 1987;68 ( Pt 5)():1351-9.
1986: Matlashewski G; Banks L; Wu-Liao J; Spence P; Pim D; Crawford L
The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies.
The Journal of general virology 1986;67 ( Pt 9)():1909-16.

Sign-in to see more